共同药业回购进展：已回购19.75万股，占总股本0.17%

Group 1 - The company announced a share repurchase plan on February 20, 2025, with a total amount not less than 20 million yuan and not exceeding 30 million yuan, at a maximum price of 23.84 yuan per share [1] - As of August 31, 2025, the company has repurchased a total of 197,500 shares, accounting for 0.17% of the current total share capital, with the highest transaction price being 16.05 yuan [1] - The company plans to continue the share repurchase based on market conditions within the approved timeframe and will fulfill information disclosure obligations as required [1]